JDRF has announced a new clinical trial to slow the development of newly diagnosed type 1 diabetes in children. The trial will test a new application of an existing drug currently approved for use in children with juvenile arthritis. [ + ]

Months after the phenomenon known as 'The Dress' hit the internet, neuroscientists have demonstrated that the optical illusion is linked to specific brain activation patterns. [ + ]

The managing director of Olympus Australia and New Zealand, James Bowe, has made his vision for the company clear, claiming that success is driven by customer relationships. [ + ]

Pharmaceutical company Merck has announced a relaunch of its brand identity in order to reflect its transformation into a global science and technology company. [ + ]

Dr Robert Crombie, the managing director of oncology company Prescient Therapeutics, has resigned in order to focus on other business opportunities. [ + ]

Eli Lilly and Company (Lilly) will terminate its phase 3 trial of the investigational medicine evacetrapib due to insufficient efficacy. [ + ]

Promega's PowerPlex Fusion 6C System has been granted approval by the FBI in the United States for use in laboratories that generate DNA records for the National DNA Index System (NDIS). [ + ]

Cynata Therapeutics will collaborate with Massachusetts General Hospital on the development of modified mesenchymal stem cells (MSCs) to treat cancer. [ + ]

The Technical University of Munich has built a technical facility for algae cultivation at its Ludwig Bölkow Campus in Ottobrunn, south of Munich. The facility will develop efficient processes for producing biokerosene and chemical products from algae. [ + ]

The 2015 AbbVie Student Poster Awards recognised the important research being carried out by Australian graduate students in areas such as pharmaceutical sciences, disease research, biology and nutritional science. [ + ]

A research team led by Sydney's Centenary Institute has discovered a significant link between breast cancer and nutrition — one which could lead to a new treatment aimed at 'starving' breast cancer cells. [ + ]

ResMed has completed its acquisition of Curative Medical, a provider of non-invasive ventilation and sleep-disordered breathing medical devices and accessories to the Chinese market. [ + ]

Scientists have created what is said to be the first 3D image of a key protein known to be involved in the development of blood and other cancers. [ + ]

Recent peer-reviewed publications have highlighted the versatility of Lonza's specialised BulletKit Growth and Differentiation Media. The papers show that the media kits are proving useful for researchers looking to transition from established cell lines to primary cell culture or when co-culturing different cell types. [ + ]

Three researchers from the Walter and Eliza Hall Institute have been elected as fellows of the Australian Academy of Health and Medical Sciences in recognition of their contributions to Australian medical research. [ + ]